Sirtuin6 is shown to deacetylate Lys54 on Smad2 to prevent liver fibrosis [55], which suggests that like acetylation, the deacetylation of SMAD2/3 varies, depending on the cell types or related disease models. Here, SMAD2 is linked to Hepatic fibrosis.